MorphoSys AG (FSE:MOR)(NASDAQ:MOR) has announced the receipt of U.S. antitrust clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) in connection with the proposed acquisition of MorphoSys by Novartis AG (“Novartis”), following the expiration of the HSR Act waiting period. MorphoSys previously also announced the receipt of antitrust clearance in Germany and Austria. As a result, the proposed acquisition of MorphoSys by Novartis has now received all mandatory regulatory approvals.
Read the full article: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis under HSR Act //
Source: https://www.accesswire.com/845738/morphosys-announces-us-antitrust-clearance-of-proposed-acquisition-by-novartis-under-hsr-act